Jesús Rodríguez

1.5k total citations
40 papers, 771 citations indexed

About

Jesús Rodríguez is a scholar working on Rheumatology, Hematology and Orthopedics and Sports Medicine. According to data from OpenAlex, Jesús Rodríguez has authored 40 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 10 papers in Hematology and 10 papers in Orthopedics and Sports Medicine. Recurrent topics in Jesús Rodríguez's work include Spondyloarthritis Studies and Treatments (16 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). Jesús Rodríguez is often cited by papers focused on Spondyloarthritis Studies and Treatments (16 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). Jesús Rodríguez collaborates with scholars based in Spain, United States and United Kingdom. Jesús Rodríguez's co-authors include Javier Narváez, D Roig-Escofet, Carmen Gómez‐Vaquero, Joan M. Nolla, Xavier Juanola, Daniel Roig-Vilaseca, José Valverde, Carmen García‐Gómez, José Antonio Narváez and R.A. Hannon and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases and Medicine.

In The Last Decade

Jesús Rodríguez

37 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Rodríguez Spain 16 443 187 178 172 124 40 771
E. Martín Mola Spain 14 650 1.5× 211 1.1× 155 0.9× 187 1.1× 156 1.3× 36 1.0k
Nianwen Shi United States 14 151 0.3× 92 0.5× 96 0.5× 149 0.9× 152 1.2× 35 631
C Tavernier France 18 276 0.6× 225 1.2× 242 1.4× 84 0.5× 435 3.5× 58 1.2k
Marina Magrey United States 21 910 2.1× 80 0.4× 165 0.9× 551 3.2× 158 1.3× 85 1.3k
C Orzincolo Italy 11 283 0.6× 39 0.2× 142 0.8× 56 0.3× 177 1.4× 70 617
Anne C. Brower United States 13 708 1.6× 137 0.7× 96 0.5× 52 0.3× 307 2.5× 39 1.0k
Carlos Rodríguez‐Lozano Spain 15 315 0.7× 40 0.2× 130 0.7× 154 0.9× 184 1.5× 46 573
Michelle Petri United States 12 1.1k 2.5× 36 0.2× 264 1.5× 700 4.1× 186 1.5× 16 1.4k
Sophie Pouplin France 16 516 1.2× 41 0.2× 36 0.2× 231 1.3× 223 1.8× 60 1.1k
Tarnya Marshall United Kingdom 18 519 1.2× 30 0.2× 122 0.7× 117 0.7× 126 1.0× 38 868

Countries citing papers authored by Jesús Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Jesús Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Rodríguez more than expected).

Fields of papers citing papers by Jesús Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Rodríguez. The network helps show where Jesús Rodríguez may publish in the future.

Co-authorship network of co-authors of Jesús Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Rodríguez. A scholar is included among the top collaborators of Jesús Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Rodríguez. Jesús Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez, Jesús, et al.. (2025). Point of care ultrasound for monitoring and resuscitation in patients with shock. Internal and Emergency Medicine. 20(5). 1505–1515.
2.
Michelena, Xabier, Sizheng Steven Zhao, Míriam Almirall, et al.. (2023). Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA. Lara D. Veeken. 63(2). 430–435. 8 indexed citations
3.
Nolla, Joan M., et al.. (2020). AB0764 SAFETY OF SYSTEMIC CORTICOSTEROIDS IN A SHORT REGIMEN IN PATIENTS WITH PSORIATIC ARTHRITIS. RETROSPECTIVE ANALYSIS OF A LARGE OBSERVATIONAL COHORT.. Annals of the Rheumatic Diseases. 79. 1680–1680. 2 indexed citations
4.
Moragues, Carmen, et al.. (2018). Axial involvement according to ASAS criteria in an observational psoriatic arthritis cohort.. PubMed. 42(2). 176–182. 5 indexed citations
5.
Deza, Gustavo, J. Notario, Marta Ferrán, et al.. (2018). Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain. Rheumatology International. 38(11). 2037–2043. 3 indexed citations
6.
Fernández‐Gutiérrez, Benjamín, Javier P. Gisbert, Eugeni Domènech, et al.. (2017). Cardiovascular disease in immune-mediated inflammatory diseases. Medicine. 96(26). e7308–e7308. 35 indexed citations
7.
Almirall, Míriam, Jesús Rodríguez, Lourdes Mateo, et al.. (2016). Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice. Clinical Rheumatology. 36(2). 439–443. 13 indexed citations
8.
9.
Cañete, Juan D., E. Daudén, Rubén Queiró, et al.. (2014). Recommendations for the Coordinated Management of Psoriatic Arthritis by Rheumatologists and Dermatologists: A Delphi Study. Actas Dermo-Sifiliográficas. 105(3). 216–232. 17 indexed citations
10.
Marí-Roig, Antonio, et al.. (2014). Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: A novel approach with anti-TNF therapy. Systematic review. Journal of Cranio-Maxillofacial Surgery. 42(8). 1990–1996. 38 indexed citations
11.
Rodríguez, Jesús, et al.. (2013). Artritis mutilante/resortiva. Estudio de 24 pacientes de una serie de 360 artritis psoriásicas. Reumatología Clínica. 9(1). 38–41. 3 indexed citations
12.
Eastell, Richard, R.A. Hannon, Dietrich Wenderoth, Jesús Rodríguez, & Andrzej Sawicki. (2011). Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover. The Journal of Clinical Endocrinology & Metabolism. 96(11). 3367–3373. 64 indexed citations
13.
Rodríguez, Jesús, et al.. (2011). Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics. Reumatología Clínica (English Edition). 7(1). 20–26. 32 indexed citations
14.
Narváez, Javier, Carmen Gómez‐Vaquero, Carmen García‐Gómez, et al.. (2009). Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.. PubMed. 26(3 Suppl 49). S57–62. 64 indexed citations
15.
Nolla, Joan M., Daniel Roig-Vilaseca, Carmen Gómez‐Vaquero, et al.. (2006). Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital.. PubMed. 33(8). 1472–5. 9 indexed citations
16.
Rodríguez, Jesús, et al.. (2005). Reforma curricular de la Carrera de Ingeniería Agronómica del Núcleo Monagas de la Universidad de Oriente. Revista Científica UDO Agrícola. 5(1). 27–39. 1 indexed citations
17.
Narváez, Javier, et al.. (1997). Posterior tibial tendon dysfunction as a cause of acquired flatfoot in the adult: value of magnetic resonance imaging. Lara D. Veeken. 36(1). 136–139. 24 indexed citations
18.
Gómez‐Vaquero, Carmen, et al.. (1996). TERMINATION OF DISEASE-MODIFYING DRUGS IN PSORIATIC ARTHRITIS: STUDY OF 109 COURSES OF TREATMENT. Lara D. Veeken. 35(6). 564–567. 5 indexed citations
19.
Rodríguez, Jesús, et al.. (1995). Hydatid disease an unusual cause of chronic monarthritis. Arthritis & Rheumatism. 38(9). 1338–1339. 4 indexed citations
20.
Roig-Escofet, D, et al.. (1989). Concept and limits of the reflex sympathetic dystrophy. Clinical Rheumatology. 8(S2). 104–108. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Martín Mola Breakdown of academic impact, for papers by Nianwen Shi Breakdown of academic impact, for papers by C Tavernier Breakdown of academic impact, for papers by Marina Magrey Breakdown of academic impact, for papers by C Orzincolo Breakdown of academic impact, for papers by Anne C. Brower Breakdown of academic impact, for papers by Carlos Rodríguez‐Lozano Breakdown of academic impact, for papers by Michelle Petri Breakdown of academic impact, for papers by Sophie Pouplin Breakdown of academic impact, for papers by Tarnya Marshall
Rankless by CCL
2026